Background illustration for clinical trials search

Paid Clinical Trials Riverside

Discover 3,012 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Los Angeles CA, Scottsdale AZ, West Valley City UT,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07383506

Phase 1, Recruiting

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

for
Aortoiliac Occlusive Disease, Peripheral Arterial Disease
Location: Long Beach CA, Denver CO, Portland OR, Wilsonville OR,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT05811364

Recruiting

Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation

for
Infertility, Female
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18 - 45

Code: NCT05505474

Recruiting

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Location: Fullerton CA, Bakersfield CA, Phoenix AZ,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07630649

Phase 2, Recruiting

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

for
EGFRI Induced Acneiform Lesions
Location: Glendale CA, Santa Monica CA, Tacoma WA, Houston TX,
Sponsor: Lutris Pharma Ltd.

Sex: All

Age: 18+

Code: NCT04759664

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

for
Persistent Corneal Epithelial Defect
Location: Redlands CA, Laguna Hills CA, Huntington Beach CA,
Sponsor: Dompé Farmaceutici S.p.A

Sex: All

Age: 18+

Code: NCT07519902

Phase 3, Recruiting

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT05989828

Phase 1, Recruiting

Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy

for
Depression, Anxiety
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 40

Code: NCT05908565

Recruiting

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

for
Polymyalgia Rheumatica
Location: Tustin CA, Temecula CA, Huntington Beach CA,
Sponsor: Sanofi

Sex: All

Age: 50+

Code: NCT07286214

Recruiting

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

for
Ovarian Cancer
Location: Torrance CA, Beverly Hills CA
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT07546500

Phase 3, Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

for
Colitis, Ulcerative, Crohn Disease
Location: Los Angeles CA, Oxnard CA, Las Vegas NV, Englewood CO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07483073

Phase 2, Recruiting

S.T.A.N.D. Alacrity Center Signature Project

for
Depression, Anxiety
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 40

Code: NCT05591937

Recruiting

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

for
Myasthenia Gravis, Generalized
Location: Pasadena CA, Houston TX, O'Fallon IL, Chicago IL,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07596901

Phase 1, Phase 2, Recruiting

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

for
Systemic Lupus Erythematosus
Location: La Palma CA, Burbank CA, Aurora CO, Red Oak TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06133972

Phase 3, Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for
Diabetic Nephropathies,
Location: Los Angeles CA, Denver CO, San Antonio TX,
Sponsor: Walden Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06466135

Phase 2, Recruiting
New

A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy

for
Glomerulonephritis, Membranous
Location: Los Angeles CA, Doral FL, Miami FL, Pembroke Pines FL
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07851220

Phase 3, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Downey CA, Long Beach CA, La Jolla CA, Phoenix AZ,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

for
Multiple Myeloma
Location: Alhambra CA, West Hollywood CA, Encinitas CA,
Sponsor: Oncotherapeutics

Sex: All

Age: 18+

Code: NCT03110822

Phase 1, Recruiting

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

for
Healthy Volunteers (HV)
Location: Glendale CA
Sponsor: Jade Biosciences, Inc.

Sex: All

Age: 18 - 55

Code: NCT07525947

Phase 1, Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: Pico Rivera CA, Bellevue WA, Richardson TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase 3, Recruiting